Clesrovimab, sold under the brand name Enflonsia, is a fully human immunoglobulin G1 kappa monoclonal antibody designed to prevent respiratory syncytial virus (RSV) infection.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.